SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009700
Filing Date
2022-05-12
Accepted
2022-05-12 16:28:43
Documents
14
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgo-20220512.htm   iXBRL 8-K 57475
2 EX-99.1 imgo-ex99_1.htm EX-99.1 188600
3 GRAPHIC img230188249_0.jpg GRAPHIC 103913
  Complete submission text file 0000950170-22-009700.txt   531967

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imgo-20220512.xsd EX-101.SCH 2488
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imgo-20220512_lab.xml EX-101.LAB 18785
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imgo-20220512_pre.xml EX-101.PRE 11594
8 EXTRACTED XBRL INSTANCE DOCUMENT imgo-20220512_htm.xml XML 4903
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 (415) 529-5055
Imago BioSciences, Inc. (Filer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40604 | Film No.: 22918288
SIC: 2834 Pharmaceutical Preparations